Nano-based eye drop: Topical and noninvasive therapy for ocular diseases
C Wang, Y Pang - Advanced drug delivery reviews, 2023 - Elsevier
Eye drops are the most accessible therapy for ocular diseases, while inevitably suffering
from their lower bioavailability which highly restricts the treatment efficacy. The introduction …
from their lower bioavailability which highly restricts the treatment efficacy. The introduction …
Chitin and its derivatives: Structural properties and biomedical applications
Chitin, a polysaccharide that occurs abundantly in nature after cellulose, has attracted the
interest of the scientific community due to its plenty of availability and low cost. Mostly, it is …
interest of the scientific community due to its plenty of availability and low cost. Mostly, it is …
Alginate based polymeric systems for drug delivery, antibacterial/microbial, and wound dressing applications
Alginates are anionic, hydrophilic polysaccharides that are derived from brown seaweeds
and bacteria. The chemical structure contains β-D-mannuronic acid (M) and α-L-guluronic …
and bacteria. The chemical structure contains β-D-mannuronic acid (M) and α-L-guluronic …
Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders
S Mandal, P Vishvakarma… - Current Drug Research …, 2024 - benthamdirect.com
According to the current information, using nano gels in the eyes have therapeutic benefits.
Industry growth in the pharmaceutical and healthcare sectors has been filled by …
Industry growth in the pharmaceutical and healthcare sectors has been filled by …
Chitosan and its derivatives for ocular delivery formulations: Recent advances and developments
A Zamboulis, S Nanaki, G Michailidou, I Koumentakou… - Polymers, 2020 - mdpi.com
Chitosan (CS) is a hemi-synthetic cationic linear polysaccharide produced by the
deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has …
deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has …
Ocular drug delivery to the anterior segment using nanocarriers: A mucoadhesive/mucopenetrative perspective
RS Dave, TC Goostrey, M Ziolkowska… - Journal of Controlled …, 2021 - Elsevier
There is a growing demand for effective treatments for ocular conditions that improve patient
compliance and reduce side-effects. While methods such as implants and injections have …
compliance and reduce side-effects. While methods such as implants and injections have …
Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications
Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness.
The disease has conventionally been characterized by an elevated intraocular pressure …
The disease has conventionally been characterized by an elevated intraocular pressure …
Nanomedicine for the detection and treatment of ocular bacterial infections
Ocular bacterial infection is a prevalent cause of blindness worldwide, with substantial
consequences for normal human life. Traditional treatments for ocular bacterial infections …
consequences for normal human life. Traditional treatments for ocular bacterial infections …
Breaking barriers in eye treatment: Polymeric nano-based drug-delivery system for anterior segment diseases and glaucoma
The eye has anatomical structures that function as robust static and dynamic barriers,
limiting the penetration, residence time, and bioavailability of medications administered …
limiting the penetration, residence time, and bioavailability of medications administered …
Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity
Purpose The topically administered drugs through conventional delivery systems have low
bioavailability. Henceforth, the present study was designed to prepare and optimize …
bioavailability. Henceforth, the present study was designed to prepare and optimize …